AI-assisted, human-published
07/16/2026 /M & A
Septa Pharmaceuticals Inc. Expands Oncology Portfolio with Acquisition of CeeNU® (Lomustine)
Septa Pharmaceuticals Inc. acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada, further expanding its specialty oncology pharmaceutical portfolio.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com